• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA 蛋白 SEMA3F 在顺铂治疗子宫内膜癌中的表达模式差异。

Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer under Cisplatin Treatment.

机构信息

Voivodeship Specialist Hospital in Wloclawek, Wloclawek, Poland.

Faculty of Health Science, Public Higher Medical Professional School in Opole, Opole, Poland.

出版信息

Curr Pharm Biotechnol. 2020;21(11):1119-1128. doi: 10.2174/1389201021666200416102540.

DOI:10.2174/1389201021666200416102540
PMID:32297576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7536788/
Abstract

BACKGROUND

Semaphorin 3F (SEMA3F) plays a substantial role in carcinogenesis, because of its role in inducing angiogenesis, and creating a microenvironment for the developing tumor.

OBJECTIVE

The purpose of this work was to assess the impact of cisplatin, depending on the concentration and exposure time on the expression pattern of SEMA3F in an endometrial cancer cell line.

MATERIALS AND METHODS

Cultures of the Ishikawa endometrial cancer cells were incubated with cisplatin with the following concentrations: 2.5μM; 5μM; and 10μM and for the following periods of time: 12; 24; and 48 hours. Cells not incubated with the drug constituted the control in the experiment. To determine the effect of cisplatin on the expression of SEMA3F, the real-time quantitative reverse transcription reaction (RtqPCR; mRNA) was used, as well as the ELISA assay (protein). The statistical analysis was done with the admission of p<0.05.

RESULTS

The silencing of SEMA3F expression on the transcriptome and proteome levels in a culture unexposed to the effects of cisplatin in comparison to endometrial cancer cells under the influence of cisplatin (p<0.05) were noted. Along with an increase in the concentration of the drug used, the number of copies of the gene transcript, during the shortest incubation period had a gradual increase. Only for the highest concentration of the drug, substantial statistical differences in the expression of the SEMA3F protein between 24 and 48 hour incubation periods (p<0.05) were determined.

CONCLUSION

Using cisplatin in an endometrial cancer cell culture results in an increased expression of SEMA3F, which advantageously affects the normalization of the neoplastic angiogenic process and lowers the proliferation of the cells making up the mass of the tumor.

摘要

背景

信号素 3F(SEMA3F)在致癌作用中起着重要作用,因为它在诱导血管生成和为肿瘤的发展创造微环境方面发挥作用。

目的

本工作旨在评估顺铂浓度和暴露时间对子宫内膜癌细胞系中 SEMA3F 表达模式的影响。

材料和方法

用以下浓度的顺铂孵育 Ishikawa 子宫内膜癌细胞:2.5μM;5μM;和 10μM,并孵育以下时间:12;24;和 48 小时。未用药物孵育的细胞构成实验中的对照。为了确定顺铂对 SEMA3F 表达的影响,使用实时定量逆转录反应(RtqPCR;mRNA)和 ELISA 测定(蛋白质)。通过承认 p<0.05 进行统计分析。

结果

在未暴露于顺铂作用的培养物中,与在顺铂作用下的子宫内膜癌细胞相比,在转录组和蛋白质组水平上观察到 SEMA3F 表达的沉默(p<0.05)。随着所用药物浓度的增加,在最短孵育时间内基因转录本的拷贝数逐渐增加。仅对于最高药物浓度,在 24 和 48 小时孵育期间,SEMA3F 蛋白表达之间存在显著的统计学差异(p<0.05)。

结论

在子宫内膜癌细胞培养中使用顺铂会导致 SEMA3F 的表达增加,这有利于正常化肿瘤血管生成过程并降低构成肿瘤质量的细胞的增殖。

相似文献

1
Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer under Cisplatin Treatment.mRNA 蛋白 SEMA3F 在顺铂治疗子宫内膜癌中的表达模式差异。
Curr Pharm Biotechnol. 2020;21(11):1119-1128. doi: 10.2174/1389201021666200416102540.
2
Evaluation of Changes in the Expression Profile of mRNA and Proteinencoding Adiponectin in Ishikawa Cell Line under the Influence of Cisplatin - Preliminary Report.顺铂作用下 Ishikawa 细胞系中脂联素编码 mRNA 和蛋白表达谱变化的评估-初步报告。
Curr Pharm Biotechnol. 2020;21(12):1242-1248. doi: 10.2174/1389201021666200506074523.
3
Cisplatin Changes Expression of SEMA3B in Endometrial Cancer.顺铂改变子宫内膜癌中 SEMA3B 的表达。
Curr Pharm Biotechnol. 2020;21(13):1368-1376. doi: 10.2174/1389201021666200514215839.
4
Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.孕酮和 1,25-二羟维生素 D₃ 通过上调神经信号蛋白 3B 和神经信号蛋白 3F 抑制子宫内膜癌细胞生长。
Mol Cancer Res. 2011 Nov;9(11):1479-92. doi: 10.1158/1541-7786.MCR-11-0213. Epub 2011 Sep 20.
5
Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.SEMA3F 表达模式随子宫内膜癌分级的变化——初步研究。
Curr Pharm Biotechnol. 2019;20(9):727-732. doi: 10.2174/1389201020666190619145655.
6
Evaluation of the Impact of Cisplatin on Variances in the Expression Pattern of Leptin-Related Genes in Endometrial Cancer Cells.评价顺铂对子宫内膜癌细胞中瘦素相关基因表达模式变化的影响。
Int J Mol Sci. 2020 Jun 10;21(11):4135. doi: 10.3390/ijms21114135.
7
Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.信号素3F(一种位于3p21.3的候选肿瘤抑制基因)在p53调控的肿瘤血管生成抑制中的可能作用。
Cancer Res. 2007 Feb 15;67(4):1451-60. doi: 10.1158/0008-5472.CAN-06-2485.
8
Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.Id2 通过抑制 Sema3F 的转录来促进肿瘤细胞迁移和侵袭。
Cancer Res. 2010 May 1;70(9):3823-32. doi: 10.1158/0008-5472.CAN-09-3048. Epub 2010 Apr 13.
9
Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.由于受DNA甲基化调控,信号素-3F在结直肠癌中发挥肿瘤抑制作用。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12766-74. eCollection 2015.
10
Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1.神经纤毛蛋白 3F 通过失活 Rac1 抑制结直肠癌细胞的干性。
Cancer Lett. 2015 Mar 1;358(1):76-84. doi: 10.1016/j.canlet.2014.12.040. Epub 2014 Dec 18.

引用本文的文献

1
Osthole suppresses the proliferation and induces apoptosis via inhibiting the PI3K/AKT signaling pathway of endometrial cancer JEC cells.蛇床子素通过抑制子宫内膜癌JEC细胞的PI3K/AKT信号通路来抑制其增殖并诱导凋亡。
Exp Ther Med. 2021 Oct;22(4):1171. doi: 10.3892/etm.2021.10605. Epub 2021 Aug 13.
2
ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.ncRNAs介导的SEMA3F高表达与肝细胞癌的不良预后和肿瘤免疫浸润相关。
Mol Ther Nucleic Acids. 2021 Apr 1;24:845-855. doi: 10.1016/j.omtn.2021.03.014. eCollection 2021 Jun 4.

本文引用的文献

1
Future Approaches to Precision Oncology-Based Clinical Trials.基于精准肿瘤学的临床试验的未来方法。
Cancer J. 2019 Jul/Aug;25(4):300-304. doi: 10.1097/PPO.0000000000000383.
2
Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.SEMA3F 表达模式随子宫内膜癌分级的变化——初步研究。
Curr Pharm Biotechnol. 2019;20(9):727-732. doi: 10.2174/1389201020666190619145655.
3
Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial.
多西他赛联合顺铂和 S-1 对比顺铂和 S-1 一线治疗晚期胃癌的疗效(JCOG1013):一项开放标签、三期、随机对照临床试验。
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):501-510. doi: 10.1016/S2468-1253(19)30083-4. Epub 2019 May 14.
4
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer.妇科癌症患者中PI3K通路抑制剂的基因组异质性与疗效
ESMO Open. 2019 Mar 8;4(2):e000444. doi: 10.1136/esmoopen-2018-000444. eCollection 2019.
5
Origin and evolution of plexins, semaphorins, and Met receptor tyrosine kinases.丛蛋白、神经递质和 Met 受体酪氨酸激酶的起源与进化。
Sci Rep. 2019 Feb 13;9(1):1970. doi: 10.1038/s41598-019-38512-y.
6
Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.3 类信号素及其受体:肿瘤进展的强效多功能调节剂。
Int J Mol Sci. 2019 Jan 28;20(3):556. doi: 10.3390/ijms20030556.
7
Role of TGF-β signaling regulatory microRNAs in the pathogenesis of colorectal cancer.转化生长因子-β信号调节性微小RNA在结直肠癌发病机制中的作用
J Cell Physiol. 2019 Sep;234(9):14574-14580. doi: 10.1002/jcp.28169. Epub 2019 Jan 26.
8
Semaphorin Signaling in Cancer-Associated Inflammation.信号素在癌症相关炎症中的作用。
Int J Mol Sci. 2019 Jan 17;20(2):377. doi: 10.3390/ijms20020377.
9
The Capability to Forecast Response to Therapy with Regard to The Time and Intensity of The Inflammatory Process in vitro in Dermal Fibroblasts Induced by IL-12.关于白细胞介素-12诱导的真皮成纤维细胞体外炎症过程的时间和强度预测治疗反应的能力。
Curr Pharm Biotechnol. 2018;19(15):1232-1240. doi: 10.2174/1389201020666190111163312.
10
Combination of ω-3 fatty acids and cisplatin as a potential alternative strategy for personalized therapy of metastatic melanoma: an in-vitro study.ω-3 脂肪酸与顺铂联合治疗转移性黑色素瘤的个性化治疗的潜在替代策略:一项体外研究。
Melanoma Res. 2019 Jun;29(3):270-280. doi: 10.1097/CMR.0000000000000564.